Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Mon, 23.09.2024
P&P Group
Fürth (Germany), 23.09.2024 – The German project developer P&P Group sold six apartment blocks in the cities of Nuremberg (four properties) and Fürth (two properties) in the third quarter of 2024 alone. The new owners of the properties in Bavaria with a total of 60 flats and around 3,800 square metres of living space are various private investo [ … ]
Mon, 23.09.2024
P&P Group
Fürth (Germany), 23.09.2024 – The German project developer P&P Group sold six apartment blocks in the cities of Nuremberg (four properties) and Fürth (two properties) in the third quarter of 2024 alone. The new owners of the properties in Bavaria with a total of 60 flats and around 3,800 square metres of living space are various private investo [ … ]
Mon, 23.09.2024
Stabilus SE
CORPORATE NEWS
Stabilus expands its Management Board to a total of three members as part of its growth strategy: CTO David Sabet will join the Management Board and be responsible for the Americas region
David Sabet will join the Management Board as of October 1, 2024 as part of the growth strategy and increasing importance of innovations as [ … ]
Mon, 23.09.2024
Stabilus SE
CORPORATE NEWS
Stabilus expands its Management Board to a total of three members as part of its growth strategy: CTO David Sabet will join the Management Board and be responsible for the Americas region
David Sabet will join the Management Board as of October 1, 2024 as part of the growth strategy and increasing importance of innovations as [ … ]
Mon, 23.09.2024
Eleving Group S.A.
Key terms of the Offering
Shares to be offered within a price range of EUR 1.60 – 1.85 per share
The offered price range implies an equity value of EUR 160-185 million before the issuance of new shares
Up to 24.5 million ordinary shares are offered
Gross proceeds target for Eleving Group up to EUR 27 million for Base Shares and up to EUR 30 mill [ … ]
Mon, 23.09.2024
Eleving Group S.A.
Key terms of the Offering
Shares to be offered within a price range of EUR 1.60 – 1.85 per share
The offered price range implies an equity value of EUR 160-185 million before the issuance of new shares
Up to 24.5 million ordinary shares are offered
Gross proceeds target for Eleving Group up to EUR 27 million for Base Shares and up to EUR 30 mill [ … ]
Mon, 23.09.2024
Springer Nature AG & Co. KGaA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE.PRESS RELEASE Springer Nature sets price range for [ … ]
Mon, 23.09.2024
Springer Nature AG & Co. KGaA
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS PRESS RELEASE.PRESS RELEASE Springer Nature sets price range for [ … ]
Mon, 23.09.2024
Hardman & Co Research
Hardman & Co Research on Tissue Regenix (TRX):
Maiden pre-tax profit
TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. Investment in tissue [ … ]
Mon, 23.09.2024
Hardman & Co Research
Hardman & Co Research on Tissue Regenix (TRX):
Maiden pre-tax profit
TRX is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL®) and bone (BioRinse®). It has a broad portfolio of products used in biosurgery, orthopaedics and dental markets. Investment in tissue [ … ]